Physicians' Academy for Cardiovascular Education

Management of cancer-associated VTE

10' education - May 12, 2022 - Prof. Stavros Konstantinides, MD - Mainz, Germany

Video navigation menu

  • Clinical practice guidelines on anticoagulation for VTE treatment 00:55
  • Association between VTE and cancer 03:21
  • Efficacy and safety of VKA and parental anticoagulants in cancer 04:17
  • Clinical benefits and caveats for DOACs in patients with cancer 06:24
  • Evolution of guideline recommendations 2019-2022 10:38


Show transcript

Educational information

This lecture by prof. Konstantinides is part of a series titled "Updates in anticoagulation management in AF and VTE".

This program provides an update of guidelines and novel findings in basic and clinical science with regard to use of anticoagulation in AF and VTE.


Prof. Stavros Konstantinides is Medical Director of the Center for Thrombosis and Hemostasis at the University Medical Center Mainz, Germany.


This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.


Funding for this educational program was provided by an unrestricted educational grant received from Bristol-Myers Squibb/Pfizer.

Find here the slides of this presentation Listen to the podcast

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.

Share this page with your colleagues and friends: